Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function

J Allergy Clin Immunol. 2016 Mar;137(3):907-18.e9. doi: 10.1016/j.jaci.2015.08.007. Epub 2015 Oct 1.

Abstract

Background: IL-5(+) pathogenic effector T(H)2 (peT(H)2) cells are a T(H)2 cell subpopulation with enhanced proinflammatory function that has largely been characterized in murine models of allergic inflammation.

Objective: We sought to identify phenotype markers for human peT(H)2 cells and characterize their function in patients with allergic eosinophilic inflammatory diseases.

Methods: Patients with eosinophilic gastrointestinal disease (EGID), patients with atopic dermatitis (AD), and nonatopic healthy control (NA) subjects were enrolled. peT(H)2 and conventional T(H)2 (cT(H)2) cell phenotype, function, and cytokine production were analyzed by using flow cytometry. Confirmatory gene expression was measured by using quantitative RT-PCR. Prostaglandin D2 levels were measured with ELISA. Gut T(H)2 cells were obtained by means of esophagogastroduodenoscopy.

Results: peT(H)2 cells were identified as chemoattractant receptor-homologous molecule expressed on T(H)2 cells-positive (CRTH2(+)), hematopoietic prostaglandin D synthase-positive CD161(hi) CD4 T cells. peT(H)2 cells expressed significantly greater IL-5 and IL-13 than did hematopoietic prostaglandin D synthase-negative and CD161(-) cT(H)2 cells. peT(H)2 cells were highly correlated with blood eosinophilia (r = 0.78-0.98) and were present in 30- to 40-fold greater numbers in subjects with EGID and those with AD versus NA subjects. Relative to cT(H)2 cells, peT(H)2 cells preferentially expressed receptors for thymic stromal lymphopoietin, IL-25, and IL-33 and demonstrated greater responsiveness to these innate pro-TH2 cytokines. peT(H)2 but not cT(H)2 cells produced prostaglandin D2. In patients with EGID and those with AD, peT(H)2 cells expressed gut- and skin-homing receptors, respectively. There were significantly greater numbers of peT(H)2 cells in gut tissue from patients with EGID versus NA subjects.

Conclusion: peT(H)2 cells are the primary functional proinflammatory human T(H)2 cell subpopulation underlying allergic eosinophilic inflammation. The unambiguous phenotypic identification of human peT(H)2 cells provides a powerful tool to track these cells in future pathogenesis studies and clinical trials.

Keywords: Atopic dermatitis; CD161; CD294; CD4; IL-5; T(H)2; chemoattractant receptor–homologous molecule expressed on T(H)2 cells; eosinophilic gastrointestinal disease; eosinophilic inflammation; hematopoietic prostaglandin D synthase.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Biomarkers
  • Cell Differentiation
  • Cell Line
  • Cytokines / metabolism
  • Disease Models, Animal
  • Eosinophils / immunology*
  • Eosinophils / metabolism*
  • Humans
  • Hypersensitivity / immunology
  • Hypersensitivity / metabolism
  • Immunity, Innate
  • Immunologic Memory
  • Immunophenotyping
  • Interleukin-5 / metabolism
  • Intramolecular Oxidoreductases / metabolism*
  • Lipocalins / metabolism*
  • Mice
  • NK Cell Lectin-Like Receptor Subfamily B / metabolism
  • Phenotype
  • Receptors, CCR / metabolism
  • Receptors, Lymphocyte Homing / metabolism
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • Th2 Cells / cytology
  • Th2 Cells / immunology*
  • Th2 Cells / metabolism*

Substances

  • Biomarkers
  • Cytokines
  • Interleukin-5
  • Lipocalins
  • NK Cell Lectin-Like Receptor Subfamily B
  • Receptors, CCR
  • Receptors, Lymphocyte Homing
  • Intramolecular Oxidoreductases
  • prostaglandin R2 D-isomerase